scholarly journals Radioactive iodine therapy may not improve disease‐specific survival in follicular variant papillary thyroid cancer without distant metastasis: A propensity score‐matched analysis

Head & Neck ◽  
2021 ◽  
Author(s):  
Xiaofei Wang ◽  
Xun Zheng ◽  
Jingqiang Zhu ◽  
Zhihui Li ◽  
Tao Wei
Keyword(s):  
Thyroid Cancer ◽  
Propensity Score ◽  
Papillary Thyroid Cancer ◽  
Distant Metastasis ◽  
Radioactive Iodine ◽  
Disease Specific Survival ◽  
Radioactive Iodine Therapy ◽  
Papillary Thyroid ◽  
Follicular Variant ◽  
Disease Specific

The Role of Radioactive Iodine Therapy in Young Patients With Papillary Thyroid Cancer

2009 ◽  
Vol 34 (1) ◽  
pp. 4-6 ◽  
Author(s):  
Sheng-Fong Kuo ◽  
Tzu-Chieh Chao ◽  
Hung-Yu Chang ◽  
Chuen Hsueh ◽  
Yu-Chen Chang ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Papillary Thyroid Cancer ◽  
Radioactive Iodine ◽  
Young Patients ◽  
Radioactive Iodine Therapy ◽  
Papillary Thyroid

scholarly journals The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER

2018 ◽  
Vol Volume 11 ◽  
pp. 3551-3560 ◽  
Author(s):  
Jianing Tang ◽  
Deguang Kong ◽  
Qiuxia Cui ◽  
Kun Wang ◽  
Dan Zhang ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Observational Study ◽  
Papillary Thyroid Cancer ◽  
Radioactive Iodine ◽  
Radioactive Iodine Therapy ◽  
Papillary Thyroid

scholarly journals Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer

2021 ◽  
Author(s):  
Andreas Machens ◽  
Kerstin Lorenz ◽  
Frank Weber ◽  
Henning Dralle
Keyword(s):  
Thyroid Cancer ◽  
Papillary Thyroid Cancer ◽  
Distant Metastasis ◽  
Medullary Thyroid Cancer ◽  
Papillary Thyroid ◽  
Follicular Thyroid Cancer ◽  
Follicular Variant ◽  
Node Negative ◽  
Medullary Thyroid ◽  
Node Metastasis

AbstractThis study of 542 patients with follicular thyroid cancer, 366 patients with the follicular variant and 1452 patients with the classical variant of papillary thyroid cancer, and 819 patients with sporadic medullary thyroid cancer operated at a tertiary referral center aimed to determine risk patterns of distant metastasis for each tumor entity, which are ill-defined. On multivariable logistic regression analyses, lymph node metastasis consistently emerged as an independent risk factor of distant metastasis, yielding odds ratios (ORs) of 2.4 and 2.8 for follicular thyroid cancer and the follicular variant of papillary thyroid cancer, and ORs of 5.9 and 6.4 for the classical variant of papillary thyroid cancer and sporadic medullary thyroid cancer. Another independent risk factor consistently associated with distant metastasis, most strongly in follicular thyroid cancer and the follicular variant of papillary thyroid cancer (OR 3.5 and 4.0), was patient age >60 years. Altogether, 2 distinct risk patterns of distant metastasis were identified, which were modulated by other cancer type-dependent risk factors: one with lymph node metastasis as leading component (classical variant of papillary thyroid cancer and sporadic medullary thyroid cancer), and another one with age as leading component (follicular thyroid cancer and the follicular variant of papillary thyroid cancer). Distant metastasis was exceptional in node-negative patients with sporadic medullary thyroid cancer (1.7%) and the classical variant of papillary thyroid cancer (1.4%), and infrequent in node-negative patients with the follicular variant of papillary thyroid cancer (4.4%). These findings delineate windows of opportunity for early surgical intervention before distant metastasis has occurred.

Financial Implication of Radioactive Iodine Therapy for Early-Stage Papillary Thyroid Cancer

Oncology ◽  
2017 ◽  
Vol 93 (2) ◽  
pp. 122-126 ◽  
Author(s):  
Zaid Al-Qurayshi ◽  
Daniah Bu Ali ◽  
Sudesh Srivastav ◽  
Emad Kandil
Keyword(s):  
Thyroid Cancer ◽  
Papillary Thyroid Cancer ◽  
Radioactive Iodine ◽  
Early Stage ◽  
Radioactive Iodine Therapy ◽  
Papillary Thyroid ◽  
Financial Implication
Sign in / Sign up

Export Citation Format

Share Document